皮肤微生物组失调与金黄色葡萄球菌在成人和儿童特应性皮炎中的作用:叙述性综述
本叙述性综述总结皮肤微生物组失调及金黄色葡萄球菌过度定植在成人和儿童特应性皮炎中的作用。特应性皮炎患者皮肤常被生物膜生长的金黄色葡萄球菌过度定植,尤其在发作期,导致微生物群失调和细菌多样性下降,且与疾病严重程度呈负相关。针对减少过度定植以恢复微生物多样性的治疗可能有助于管理特应性皮炎并减少发作。
要点
- 特应性皮炎患者皮肤常被生物膜生长的金黄色葡萄球菌过度定植,尤其在发作期。
- 皮肤微生物群失调和细菌多样性下降与特应性皮炎严重程度呈负相关。
- 针对减少金黄色葡萄球菌过度定植以恢复微生物多样性的治疗可能有助于管理特应性皮炎并减少发作。
核心结论
- 针对皮肤微生物组失调和金黄色葡萄球菌过度定植的治疗可能有助于管理成人和儿童特应性皮炎并减少发作。
研究设计与样本
- 叙述性综述,总结关于靶向皮肤微生物组失调和金黄色葡萄球菌过度定植以治疗成人和儿童特应性皮炎的最新数据。
主要发现
- 特应性皮炎患者皮肤常被生物膜生长的金黄色葡萄球菌过度定植,尤其在发作期,导致皮肤微生物群失调和细菌多样性下降,且与特应性皮炎严重程度呈负相关。
- 皮肤微生物组的特定变化可在婴儿期临床特应性皮炎发病前出现。
- 儿童和成人之间局部皮肤解剖、脂质含量、pH、水活度和皮脂分泌存在差异,且通常与主要微生物群相关。
临床怎么用
- 间接特应性皮炎疗法(包括润肤剂「plus」、抗炎外用药物和单克隆抗体)可能对金黄色葡萄球菌产生影响并有助于控制细菌多样性。
- 直接疗法(包括抗菌治疗(消毒剂/外用或全身抗生素)和专门靶向金黄色葡萄球菌的创新治疗(如抗金黄色葡萄球菌内溶素和自体细菌疗法))可能作为有效替代方案,以减轻微生物耐药性的增加并使共生微生物群比例适当增加。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A dysfunctional epidermal barrier, which may be associated with mutations in the filaggrin gene in genetically predisposed individuals or harmful effects of environmental agents and allergens, contributes to the development of atopic dermatitis (AD) due to an interplay between the epithelial barrier, immune defence and the cutaneous microbiome. The skin of patients with AD is frequently over-colonized by biofilm-growing Staphylococcus aureus, especially during flares, causing dysbiosis of the cutaneous microbiota and a decrease in bacterial diversity that inversely correlates with AD severity. Specific changes in the skin microbiome can be present before clinical AD onset in infancy. Additionally, local skin anatomy, lipid content, pH, water activity and sebum secretion differ between children and adults and generally correlate with the predominant microbiota. Considering the importance of S. aureus in AD, treatments aimed at reducing over-colonization to rebalance microbial diversity may help manage AD and reduce flares. Anti-staphylococcal interventions in AD will contribute to a decrease in S. aureus superantigens and proteases that cause damage and inflammation of the skin barrier while concomitantly increasing the proportion of commensal bacteria that secrete antimicrobial molecules that protect healthy skin from invading pathogens. This review summarizes the latest data on targeting skin microbiome dysbiosis and S. aureus over-colonization to treat AD in adults and children. Indirect AD therapies, including emollients 'plus', anti-inflammatory topicals and monoclonal antibodies, may have an impact on S. aureus and help control bacterial diversity. Direct therapies, including antibacterial treatments (antiseptics/topical or systemic antibiotics), and innovative treatments specifically targeting S. aureus (e.g. anti-S. aureus endolysin, and autologous bacteriotherapy), may be effective alternatives to mitigate against an increase in microbial resistance and allow a proportionate increase in the commensal microbiota.
引用
- Demessant-Flavigny AL, Connétable S, Kerob D, et al. Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review. J Eur Acad Dermatol Venereol. 2023. PMID: 37232427. doi:10.1111/jdv.19125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。